Core Insights - Aqemia is a pioneering TechBio company that combines generative AI and quantum-inspired physics to invent drugs [1] - The company will be represented by CEO Maximilien Levesque and VP Finance Théa Vu-Bignand at the Jefferies Global Healthcare Conference in London from November 17 – 20, 2025 [1] - Aqemia's platform, QEMI, allows for the design of novel drug candidates in a repeatable, frugal, and scalable manner [1]